Triamcinolone Acetonide

ANDA 87798, held by Actavis Mid Atlantic. Triamcinolone Acetonide.

As of Nov 15, 2026, ANDA 87798 (Triamcinolone Acetonide), held by Actavis Mid Atlantic, was first approved by FDA on Jun 4, 1982, with 20 approved supplements and 0 published complete response letters.

First approved: Jun 4, 1982
Supplements approved: 20
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 21 submissions below

Date	Submission	Status	Documents
Jun 4, 1982	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Triamcinolone Acetonide0.1% · cream;topical	Triamcinolone Acetonide	Discontinued

All 21 submissions, including labeling and manufacturing supplements


May 30, 2001	Supplement 24Manufacturing	Approved	None posted
Dec 29, 2000	Supplement 23Manufacturing	Approved	None posted
Sep 25, 2000	Supplement 22Manufacturing	Approved	None posted
Jun 23, 1997	Supplement 19Manufacturing	Approved	None posted
Jun 23, 1997	Supplement 18Manufacturing	Approved	None posted
Jun 23, 1997	Supplement 17Manufacturing	Approved	None posted
Jun 23, 1997	Supplement 16Manufacturing	Approved	None posted
May 12, 1997	Supplement 21Manufacturing	Approved	None posted
Jun 28, 1996	Supplement 20Manufacturing	Approved	None posted
Feb 7, 1996	Supplement 15Manufacturing	Approved	None posted
Jul 24, 1995	Supplement 14Manufacturing	Approved	None posted
Feb 11, 1991	Supplement 13Labeling	Approved	None posted
Jul 26, 1989	Supplement 12Manufacturing	Approved	None posted
Jul 26, 1989	Supplement 11Manufacturing	Approved	None posted
Jun 15, 1988	Supplement 9Manufacturing	Approved	None posted
Jun 15, 1988	Supplement 7Manufacturing	Approved	None posted
Dec 20, 1985	Supplement 5Manufacturing	Approved	None posted
Mar 31, 1983	Supplement 4Manufacturing	Approved	None posted
Mar 21, 1983	Supplement 3Manufacturing	Approved	None posted
Feb 14, 1983	Supplement 1Manufacturing	Approved	None posted
Jun 4, 1982	Original application	Approved	None posted

Identifiers

Application: ANDA 87798
Drugs@FDA: Overview at FDA
Company: Actavis Mid Atlantic LLC

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters